How effective is ensidipine?

Enasidenib has shown efficacy in the treatment of patients with relapsed or refractory acute myeloid leukemia (AML) who have specific IDH2 gene mutations. Clinical trial results show that some patients have experienced remission and improved survival and quality of life after receiving ensidipine treatment. However, the efficacy of ensidipine varies from person to person and may be accompanied by some side effects, such as nausea, vomiting, diarrhea, etc. Therefore, before using ensidipine, patients should consult a professional doctor to evaluate whether their condition and physical condition are suitable for using this drug, and follow the doctor's guidance for standardized treatment. At the same time, patients should also pay attention to regular clinical monitoring to ensure the efficacy and safety of the drug.